Natixis Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $121M | Buy |
954,962
+3,055
| +0.3% | +$403K | 0.14% | 149 |
|
|
2026
Q1 | $133M | Buy |
951,907
+175,668
| +23% | +$24.6M | 0.18% | 123 |
|
|
2025
Q4 | $95.3M | Buy |
776,239
+129,843
| +20% | +$15.8M | 0.14% | 156 |
|
|
2025
Q3 | $71.8M | Buy |
646,396
+17,725
| +3% | +$2.01M | 0.1% | 195 |
|
|
2025
Q2 | $69.7M | Buy |
628,671
+128,488
| +26% | +$13.7M | 0.11% | 194 |
|
|
2025
Q1 | $56M | Buy |
500,183
+165,446
| +49% | +$17.1M | 0.1% | 206 |
|
|
2024
Q4 | $30.9M | Buy |
334,737
+165,374
| +98% | +$14.9M | 0.06% | 320 |
|
|
2024
Q3 | $14.2M | Buy |
169,363
+25,912
| +18% | +$1.98M | 0.03% | 546 |
|
|
2024
Q2 | $9.84M | Sell |
143,451
-35,988
| -20% | -$2.4M | 0.02% | 611 |
|
|
2024
Q1 | $13.1M | Sell |
179,439
-100,181
| -36% | -$7.7M | 0.03% | 520 |
|
|
2023
Q4 | $22.7M | Buy |
279,620
+36,711
| +15% | +$2.86M | 0.06% | 325 |
|
|
2023
Q3 | $18.2M | Sell |
242,909
-2,082
| -0.8% | -$160K | 0.06% | 343 |
|
|
2023
Q2 | $18.9M | Sell |
244,991
-9,610
| -4% | -$766K | 0.06% | 339 |
|
|
2023
Q1 | $21.1M | Buy |
254,601
+59,489
| +30% | +$4.93M | 0.07% | 287 |
|
|
2022
Q4 | $16.8M | Buy |
195,112
+35,725
| +22% | +$2.83M | 0.06% | 337 |
|
|
2022
Q3 | $9.83M | Buy |
159,387
+22,941
| +17% | +$1.45M | 0.04% | 438 |
|
|
2022
Q2 | $8.43M | Buy |
136,446
+68,104
| +100% | +$4.22M | 0.04% | 483 |
|
|
2022
Q1 | $4.06M | Sell |
68,342
-97,689
| -59% | -$6.24M | 0.02% | 747 |
|
|
2021
Q4 | $12.1M | Buy |
166,031
+24,324
| +17% | +$1.68M | 0.05% | 404 |
|
|
2021
Q3 | $9.9M | Buy |
141,707
+3,640
| +3% | +$256K | 0.04% | 424 |
|
|
2021
Q2 | $9.51M | Buy |
138,067
+27,658
| +25% | +$1.85M | 0.04% | 424 |
|
|
2021
Q1 | $7.13M | Buy |
110,409
+24,550
| +29% | +$1.58M | 0.04% | 480 |
|
|
2020
Q4 | $5M | Sell |
85,859
-15,941
| -16% | -$962K | 0.03% | 558 |
|
|
2020
Q3 | $6.43M | Sell |
101,800
-66,944
| -40% | -$4.64M | 0.04% | 441 |
|
|
2020
Q2 | $13M | Sell |
168,744
-18,688
| -10% | -$1.43M | 0.09% | 265 |
|
|
2020
Q1 | $14M | Buy |
187,432
+97,251
| +108% | +$6.72M | 0.11% | 204 |
|
|
2019
Q4 | $5.86M | Sell |
90,181
-7,193
| -7% | -$468K | 0.04% | 475 |
|
|
2019
Q3 | $6.17M | Sell |
97,374
-686
| -0.7% | -$44.8K | 0.05% | 411 |
|
|
2019
Q2 | $6.63M | Buy |
98,060
+13,175
| +16% | +$867K | 0.05% | 377 |
|
|
2019
Q1 | $5.52M | Sell |
84,885
-14,355
| -14% | -$954K | 0.05% | 420 |
|
|
2018
Q4 | $6.21M | Sell |
99,240
-1,296
| -1% | -$90.6K | 0.06% | 339 |
|
|
2018
Q3 | $7.76M | Sell |
100,536
-41,137
| -29% | -$3.11M | 0.07% | 319 |
|
|
2018
Q2 | $10M | Sell |
141,673
-12,811
| -8% | -$905K | 0.1% | 249 |
|
|
2018
Q1 | $11.6M | Buy |
154,484
+23,256
| +18% | +$1.85M | 0.12% | 200 |
|
|
2017
Q4 | $9.4M | Sell |
131,228
-15,288
| -10% | -$1.16M | 0.1% | 249 |
|
|
2017
Q3 | $11.9M | Buy |
146,516
+39,009
| +36% | +$2.98M | 0.13% | 193 |
|
|
2017
Q2 | $7.61M | Sell |
107,507
-1,061
| -1% | -$70.6K | 0.08% | 287 |
|
|
2017
Q1 | $7.37M | Buy |
108,568
+3,272
| +3% | +$230K | 0.08% | 297 |
|
|
2016
Q4 | $7.54M | Sell |
105,296
-17,662
| -14% | -$1.31M | 0.09% | 274 |
|
|
2016
Q3 | $9.73M | Sell |
122,958
-46,470
| -27% | -$3.77M | 0.13% | 204 |
|
|
2016
Q2 | $14.1M | Buy |
169,428
+14,813
| +10% | +$1.31M | 0.2% | 125 |
|
|
2016
Q1 | $14.2M | Buy |
154,615
+25,817
| +20% | +$2.33M | 0.21% | 109 |
|
|
2015
Q4 | $13M | Sell |
128,798
-15,360
| -11% | -$1.6M | 0.21% | 100 |
|
|
2015
Q3 | $14.2M | Sell |
144,158
-12,717
| -8% | -$1.41M | 0.25% | 80 |
|
|
2015
Q2 | $18.4M | Buy |
156,875
+9,445
| +6% | +$1.03M | 0.31% | 56 |
|
|
2015
Q1 | $14.5M | Buy |
147,430
+14,029
| +11% | +$1.42M | 0.25% | 80 |
|
|
2014
Q4 | $12.6M | Buy |
133,401
+14,610
| +12% | +$1.51M | 0.24% | 88 |
|
|
2014
Q3 | $12.6M | Buy |
118,791
+7,441
| +7% | +$729K | 0.25% | 76 |
|
|
2014
Q2 | $9.23M | Buy |
111,350
+9,801
| +10% | +$763K | 0.13% | 238 |
|
|
2014
Q1 | $7.2M | Sell |
101,549
-6,389
| -6% | -$501K | 0.11% | 311 |
|
|
2013
Q4 | $8.11M | Buy |
107,938
+9,828
| +10% | +$684K | 0.13% | 248 |
|
|
2013
Q3 | $6.17M | Buy |
98,110
+9,652
| +11% | +$577K | 0.11% | 307 |
|
|
2013
Q2 | $4.54M | Buy |
+88,458
| New | +$4.61M | 0.09% | 368 |
|
Other funds holding GILD
Natixis Advisors's GILD Position: Q2 2026 in Review
Natixis Advisors increased its Gilead Sciences (GILD) stake by 0.32% in Q2 2026, buying an estimated $403K and bringing the position to 954,962 shares worth $121M. The position accounts for 0.14% of the portfolio, ranked #149.
Natixis Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $133M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Natixis Advisors held 954,962 shares of Gilead Sciences worth $121M as of Q2 2026.
- Natixis Advisors bought 3,055 Gilead Sciences shares in Q2 2026, an estimated $403K.
- Gilead Sciences made up 0.14% of Natixis Advisors's portfolio in Q2 2026, its #149 holding.
- Natixis Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Natixis Advisors's Gilead Sciences position peaked at $133M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.